Recall of Certain Injectable Drugs (Nov. 2005)

Central Admixture Pharmacy Services (CAPS) is recalling certain injectable drug products because they may not be sterile. Using non-sterile injectables could lead to life-threatening patient injury or even death.

The recall covers all injectable products made by CAPS at the company's Lanham, Maryland location. They include:
• cardioplegia solutions
• oxytocin injectables
• dialysate solutions
• TPN products
• magnesium-containing injectable products
• promethazine
• bupivicaine
• diltiazem
• norepinephrine
• cefazolin
• heparin replacement solutions

The company distributed the affected products to hospitals in Maryland, Delaware, Washington, D.C., and Virginia. At this time, only injectables made at the CAPS Lanham site are included in this recall.

CAPS has directly notified known hospital customers about the recall, but FDA is urging hospitals, physicians, and health care workers to examine their supplies for any CAPS injectable products made at the Lanham, MD facility. If you have these products, stop using them immediately and quarantine them. Also, please notify FDA of any complaints or problems with these products.

Additional Information:

FDA MedWatch Safety Alert - Injectable Products made by Central Admixture Pharmacy Service (CAPS) of Lanham, Maryland.
http://www.fda.gov/medwatch/safety/2005/safety05.htm#CAPS

Category:

News & Politics

Tags:

• Recall
• Non-Sterile
• Injectable
• Drugs
• FDA
• Central
• Admixture
• Pharmacy
• Services
• Patient
• Safety
• Lanham
• Death